Figure legend.
Figure 1. A. MRI in the acute onset of cerebral dysfunction demonstrated a focal area of hyperintensity in the right centrum semiovale with diffusion restriction (white arrow). B.48 hours after, MRI revealed no more lessions and showed more clearly a focal white matter hyperintensity with diffusion restriction (white arrow).
References
1. Watanabe K, Arakawa Y, Oguma E, et al. Characteristics of methotrexate-induced stroke-like neurotoxicity. International journal of hematology. 2018;108(6):630-636.
2. Millan NC, Pastrana A, Guitter MR, Zubizarreta PA, Monges MS, Felice MS. Acute and sub-acute neurological toxicity in children treated for acute lymphoblastic leukemia. Leukemia research. 2018;65:86-93.
3. Bhojwani D, Sabin ND, Pei D, et al. Methotrexate-induced neurotoxicity and leukoencephalopathy in childhood acute lymphoblastic leukemia. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014;32(9):949-959.
4. Cruz-Carreras MT, Chaftari P, Shamsnia A, Guha-Thakurta N, Gonzalez C. Methotrexate-induced leukoencephalopathy presenting as stroke in the emergency department. Clinical case reports.2017;5(10):1644-1648.
5. Rogers P, Pan WJ, Drachtman RA, Haines C. A Stroke Mimic: Methotrexate-induced Neurotoxicity in the Emergency Department.The Journal of emergency medicine. 2017;52(4):559-561.
6. Iwatani K, Fujii N, Deguchi S, Tanimoto M. Subacute methotrexate-related leukoencephalopathy with stroke-like presentation.International journal of hematology. 2012;96(6):683-684.
7. Bond J, Hough R, Moppett J, Vora A, Mitchell C, Goulden N. ’Stroke-like syndrome’ caused by intrathecal methotrexate in patients treated during the UKALL 2003 trial. Leukemia.2013;27(4):954-956.
8. Valle DA, Kakehasi FM, Melo RM, Siqueira CM, Soares TF, Rodrigues KE. Stroke-like encephalopathy following high-dose intravenous methotrexate in an adolescent with osteosarcoma: a case report. Revista brasileira de hematologia e hemoterapia. 2016;38(4):364-367.
9. Afshar M, Birnbaum D, Golden C. Review of dextromethorphan administration in 18 patients with subacute methotrexate central nervous system toxicity. Pediatric neurology. 2014;50(6):625-629.
10. Vijayanathan V, Gulinello M, Ali N, Cole PD. Persistent cognitive deficits, induced by intrathecal methotrexate, are associated with elevated CSF concentrations of excitotoxic glutamate analogs and can be reversed by an NMDA antagonist. Behavioural brain research.2011;225(2):491-497.